These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15289021)

  • 1. Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines.
    Länger F; Stickel J; Tessema M; Kreipe H; Lehmann U
    Leuk Res; 2004 Oct; 28(10):1081-3. PubMed ID: 15289021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
    Kurata M; Hasegawa M; Nakagawa Y; Abe S; Yamamoto K; Suzuki K; Kitagawa M
    Exp Mol Pathol; 2006 Dec; 81(3):249-54. PubMed ID: 16566920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction.
    Miyazato A; Ueno S; Ohmine K; Ueda M; Yoshida K; Yamashita Y; Kaneko T; Mori M; Kirito K; Toshima M; Nakamura Y; Saito K; Kano Y; Furusawa S; Ozawa K; Mano H
    Blood; 2001 Jul; 98(2):422-7. PubMed ID: 11435312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
    de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
    Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
    Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of increased expression of DLK1 gene on the pathogenesis of myelodysplastic syndromes.
    Ma X; Zhang Y; Yang L; Xu Z; Xiao Z
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):261-8. PubMed ID: 22513084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O
    Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.
    Qi X; Chen Z; Liu D; Cen J; Gu M
    Int J Mol Med; 2008 Jul; 22(1):61-8. PubMed ID: 18575777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia.
    Mahadevan D; DiMento J; Croce KD; Riley C; George B; Fuchs D; Mathews T; Wilson C; Lobell M
    Am J Hematol; 2006 Oct; 81(10):779-86. PubMed ID: 16838325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.
    Hussein K; Theophile K; Büsche G; Schlegelberger B; Göhring G; Kreipe H; Bock O
    Leuk Res; 2010 Mar; 34(3):328-34. PubMed ID: 19615744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
    Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
    Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the Doppel protein in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E; Comincini S; Benatti C; Azzalin A; Nano R; Rosti V; Ferretti L; Invernizzi R
    Br J Haematol; 2005 Mar; 128(6):877-84. PubMed ID: 15755294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cell cycle control genes in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Cao YR; Wang XL; Tu MF
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):10-4. PubMed ID: 15946501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
    Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
    Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis].
    Qian J; Chen ZX; Wang W; Cen JN; Xue YQ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1260-4. PubMed ID: 15387962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome.
    Heinrichs S; Berman JN; Ortiz TM; Kornblau SM; Neuberg DS; Estey EH; Look AT
    Br J Haematol; 2005 Jul; 130(1):83-6. PubMed ID: 15982348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.